NEAL KLEIMAN to Paclitaxel
This is a "connection" page, showing publications NEAL KLEIMAN has written about Paclitaxel.
Connection Strength
0.411
-
Rapid adoption of drug-eluting stents: clinical practices and outcomes from the early drug-eluting stent era. Am Heart J. 2010 Oct; 160(4):767-74.
Score: 0.230
-
In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv. 2009 Aug; 2(8):767-75.
Score: 0.053
-
Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA. 2007 May 09; 297(18):2001-9.
Score: 0.045
-
Evolving revascularization approaches for myocardial ischemia. Am J Cardiol. 2003 Nov 07; 92(9B):9N-17N.
Score: 0.036
-
Acute myocardial infarction and cardiac arrest in a patient receiving paclitaxel. Can J Cardiol. 2003 Mar 15; 19(3):300-2.
Score: 0.034
-
Patterns of activation and deposition of platelets exposed to the polymeric surface of the paclitaxel eluting stent. J Thromb Thrombolysis. 2010 Jan; 29(1):60-9.
Score: 0.014